These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Dynamics of cytomegalovirus (CMV) plasma DNAemia in initial and recurrent episodes of active CMV infection in the allogeneic stem cell transplantation setting: implications for designing preemptive antiviral therapy strategies. Muñoz-Cobo B; Solano C; Costa E; Bravo D; Clari MÁ; Benet I; Remigia MJ; Montoro J; Navarro D Biol Blood Marrow Transplant; 2011 Nov; 17(11):1602-11. PubMed ID: 21871245 [TBL] [Abstract][Full Text] [Related]
23. Differences in cytomegalovirus plasma viral loads measured in allogeneic hematopoietic stem cell transplant recipients using two commercial real-time PCR assays. Gracia-Ahufinger I; Tormo N; Espigado I; Solano C; Urbano-Ispizua A; Clari MA; de la Cruz-Vicente F; Navarro D; Pérez-Romero P J Clin Virol; 2010 Jun; 48(2):142-6. PubMed ID: 20395168 [TBL] [Abstract][Full Text] [Related]
24. Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic stem cell transplantation. Mori T; Okamoto S; Watanabe R; Yajima T; Iwao Y; Yamazaki R; Nakazato T; Sato N; Iguchi T; Nagayama H; Takayama N; Hibi T; Ikeda Y Bone Marrow Transplant; 2002 May; 29(9):777-82. PubMed ID: 12040476 [TBL] [Abstract][Full Text] [Related]
25. Significance of qualitative PCR detection method for preemptive therapy of cytomegalovirus infection in patients after allogeneic hematopoietic stem cell transplantation -- single-centre experience. Skapova D; Racil Z; Dvorakova D; Minarikova D; Mayer J Neoplasma; 2005; 52(2):137-42. PubMed ID: 15800712 [TBL] [Abstract][Full Text] [Related]
26. A randomised trial comparing cytomegalovirus antigenemia assay vs screening bronchoscopy for the early detection and prevention of disease in allogeneic bone marrow and peripheral blood stem cell transplant recipients. Humar A; Lipton J; Welsh S; Moussa G; Messner H; Mazzulli T Bone Marrow Transplant; 2001 Sep; 28(5):485-90. PubMed ID: 11593322 [TBL] [Abstract][Full Text] [Related]
27. Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients. Matsunaga T; Sakamaki S; Ishigaki S; Kohda K; Takeda M; Katoh J; Kuroda H; Hirayama Y; Kusakabe T; Akiyama T; Kuga T; Niitsu Y; Masaoka T; Sagawa T; Matsumoto Y Int J Hematol; 1999 Feb; 69(2):105-11. PubMed ID: 10071460 [TBL] [Abstract][Full Text] [Related]
28. Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients. Brytting M; Mousavi-Jazi M; Boström L; Larsson M; Lunderberg J; Ljungman P; Ringdén O; Sundqvist VA Transplantation; 1995 Nov; 60(9):961-5. PubMed ID: 7491701 [TBL] [Abstract][Full Text] [Related]
29. Comparison of pp65 antigenemia, quantitative PCR and DNA hybrid capture for detection of cytomegalovirus in transplant recipients and AIDS patients. Mhiri L; Kaabi B; Houimel M; Arrouji Z; Slim A J Virol Methods; 2007 Jul; 143(1):23-8. PubMed ID: 17336402 [TBL] [Abstract][Full Text] [Related]
30. Quantitation of cytomegalovirus DNA by the polymerase chain reaction as a predictor of disease in solid organ transplantation. Ghisetti V; Barbui A; Franchello A; Varetto S; Pittaluga F; Bobbio M; Salizzoni M; Marchiaro G J Med Virol; 2004 Jun; 73(2):223-9. PubMed ID: 15122796 [TBL] [Abstract][Full Text] [Related]
31. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value. Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429 [TBL] [Abstract][Full Text] [Related]